- Home
- NATH vs ETON Comparison
NATH vs ETON Comparison
Compare NATH & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NATH
- ETON
- Stock Information
- Founded
- NATH 1916
- ETON 2017
- Country
- NATH United States
- ETON United States
- Employees
- NATH N/A
- ETON N/A
- Industry
- NATH Restaurants
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- NATH Consumer Discretionary
- ETON Health Care
- Exchange
- NATH Nasdaq
- ETON Nasdaq
- Market Cap
- NATH 330.5M
- ETON 329.8M
- IPO Year
- NATH N/A
- ETON 2018
- Fundamental
- Price
- NATH $92.86
- ETON $14.42
- Analyst Decision
- NATH
- ETON Strong Buy
- Analyst Count
- NATH 0
- ETON 3
- Target Price
- NATH N/A
- ETON $27.67
- AVG Volume (30 Days)
- NATH 13.7K
- ETON 248.9K
- Earning Date
- NATH 02-06-2025
- ETON 03-18-2025
- Dividend Yield
- NATH 2.11%
- ETON N/A
- EPS Growth
- NATH 24.88
- ETON N/A
- EPS
- NATH 5.80
- ETON N/A
- Revenue
- NATH $146,386,000.00
- ETON $39,011,000.00
- Revenue This Year
- NATH N/A
- ETON $107.69
- Revenue Next Year
- NATH N/A
- ETON $65.50
- P/E Ratio
- NATH $16.47
- ETON N/A
- Revenue Growth
- NATH 6.83
- ETON 23.29
- 52 Week Low
- NATH $64.02
- ETON $3.03
- 52 Week High
- NATH $104.96
- ETON $18.41
- Technical
- Relative Strength Index (RSI)
- NATH 48.20
- ETON 45.14
- Support Level
- NATH $91.40
- ETON $12.73
- Resistance Level
- NATH $96.39
- ETON $15.73
- Average True Range (ATR)
- NATH 2.09
- ETON 0.91
- MACD
- NATH -0.92
- ETON 0.00
- Stochastic Oscillator
- NATH 18.99
- ETON 56.17
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.